Are EA rates resuming their upward trend?
A number of observers have noted that the incidence of esophageal adenocarcinoma (EA) appeared to plateau beginning in the early
Worldwide esophageal cancer burden - 2020 to 2040
IARC's GLOBOCAN database was used to estimate the worldwide esophageal cancer burden in 2020, and to project to
More evidence supporting need for individualized EA screening
Since approximately 40% of esophageal adenocarcinoma cases arise in persons without significant gastroesophageal reflux (Nat Rev Cancer 2015), it has
Diet and risk of Barrett's
This thoughtful and thorough analysis of food frequency dietary data from the Melbourne Cohort Study supports previous research indicating that
Cost-effectiveness modeling suggests more targeted screening for esophageal adenocarcinoma
Given that the incidence of esophageal adenocarcinoma in the U.S. varies dramatically by sex and race, it seems likely
Significant updates to Barrett's screening, surveillance and treatment guidelines
Important guideline updates include the recommendations for nonendoscopic screening methods, longer intervals for short-segment BE surveillance, and specific suggestions for
Esophageal adenocarcinoma incidence increases in Netherlands
The authors calculated temporal trends in esophageal adenocarcinoma from 1989-2016 in the Netherlands, finding substantial increases. They projected rates about
Alcohol and esophageal squamous cell carcinoma in east Africa
A large multi-center study across three countries in east Africa confirms the significant role that alcohol intake plays in the
Opportunities for esophageal cancer screening
Using the VA Central Cancer Registry, the authors investigated opportunites to undergo screening for esophageal adenocarcinoma (EAC), finding more than
Indicators of prognosis among patients with esophageal adecnocarcinoma
Dr. Matt Buas and colleagues analyzed clinical and lifestyle factors among 371 persons with esophageal adenocarcinoma. A number of factors
